Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketoreductase BsSDR10 Mutagenesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118755682A reveals BsSDR10 mutants for tetrabenazine reduction. Discover cost-effective, high-selectivity biocatalytic solutions for chiral drug manufacturing.